Pathogenic role of human papillomavirus (HPV) DNA Integration and clonal expansion in cervical tumorigenesis
人乳头瘤病毒 (HPV) DNA 整合和克隆扩增在宫颈肿瘤发生中的致病作用
基本信息
- 批准号:10507371
- 负责人:
- 金额:$ 26.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-09 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AwardBar CodesBiological AssayCRISPR-mediated transcriptional activationCRISPR/Cas technologyCancer EtiologyCarcinomaCell Culture TechniquesCell CycleCellsCervicalCervical Intraepithelial NeoplasiaCervical dysplasiaCervix NeoplasmsCervix carcinomaCircular DNAClinicalClonal EvolutionClonal ExpansionClustered Regularly Interspaced Short Palindromic RepeatsCollectionColorContact InhibitionCustomDNADNA IntegrationDNA StructureDNA sequencingDevelopmentDiseaseDysplasiaEpisomeEpithelialEventFluorescent in Situ HybridizationFundingGenesGenomeGenomic DNAGenomic InstabilityGenomicsGoalsGrowthGuide RNAHPV-High RiskHistologicHumanHuman EngineeringHuman GenomeHuman PapillomavirusHuman papilloma virus 45Human papilloma virus infectionHuman papillomavirus 16Human papillomavirus 18IndividualInfectionInterphaseK-Series Research Career ProgramsKnowledgeLabelLaboratoriesLaboratory ResearchLentivirusLesionLocationMalignant NeoplasmsMalignant neoplasm of cervix uteriMapsMentorsMethodologyMethodsModelingMolecularMolecular StructureNormal CellNucleotidesOncogenesOncogenicOutcomePVT1 genePathogenicityPatientsPhasePhenotypePlasmidsPopulationPositioning AttributePropertyRecombinantsRecurrenceResearchResearch DesignResearch PersonnelResolutionRoleSamplingScienceScientistSequencing By HybridizationsSiteSystemTechnologyTestingTimeTrainingTranscriptional ActivationTransfectionViralViral GenomeViral OncogeneWomanbasecareerds-DNAgenetic testinghuman DNAinsightintegration siteinterestkeratinocytelaboratory experiencemigrationnext generation sequencingnovelpremalignantprogramspromoterskillsspatiotemporaltooltranscriptomicstumortumorigenesistumorigenicviral DNA
项目摘要
Summary/Abstract
Infection with high-risk Human Papillomavirus (hrHPV) is a necessary, key event in cervical
carcinoma. A major advance in understanding cervical cancer was the recognition that HPV DNA is integrated
into the human genome in almost all advanced cervical tumors. Human genome integration of HPV DNA 1)
stably associates the viral oncogenes with a host cell, 2) potentially drives expression of host oncogenes that
flank the sites of HPV DNA insertions, and 3) also causes human genome rearrangements. HPV integration is
thought to occur randomly in the human genome, but integrated HPV DNA in tumors is often inserted at one of
dozens of common genes in independent tumors, which suggests a clonal proliferation and survival advantage
of cells containing insertions at these positions. During the initial phase of my research laboratory training, I
developed an extensive, nascent research program to 1) detect and map HPV-human DNA junctions at single
nucleotide resolution (hybridization capture + next generation sequencing, HC+NGS), 2) thoroughly
characterize integrated viral DNA structure, and 3) describe the transcriptomic landscape in both cervical
dysplasia and carcinoma clinical samples. I also applied the HC+NGS assay to a recently developed cell
culture model where HPV circular DNA episomes replicate in early passage, human primary keratinocytes. I
found that HPV DNA integration occurs efficiently in this model, thus providing a potent system to study HPV
DNA integration and its functional consequences. To my knowledge, this is the first system for performing this
type of study. I detected HPV integrated into multiple sites in the human genome, some of which were detected
multiple times indicating clonal expansion of cells containing them. I hypothesize that HPV DNA integration is a
key molecular event that promotes clonal expansion of cells, and promotes the development of dysplasia and
invasive cervical carcinoma. In this application, I seek to develop my laboratory skills by generating and using
new tools to study the spatio-temporal consequences of HPV integration on clonal expansion in patient
derived, progressive cervical dysplasia lesions using multi-color, interphase DNA FISH assays (Aim 1); assess
tumorigenic properties of cultured keratinocytes (Aim 2) and finally to test the role of transcriptional activation
of flanking human genes in the expanded clonal populations (AIM 3). I will utilize a novel barcoding system
based on CRISPR activation of GFP in clones of interest combined with a custom recombinant HPV quasivirus
approach to lineage trace expanded HPV DNA integrated clones. I will carry out the proposed research over a
5 year period as part of a comprehensive K08 Career Development Award. Along with my co-mentors, Dr.
Cristina Montagna and Dr. Jack Lenz, we have developed a training plan focusing on laboratory science and
methodology to achieve my career goal of becoming a fully independent and funded clinician scientist.
摘要/摘要
高风险人乳头瘤病毒(HRHPV)感染是宫颈中必要的关键事件
癌。理解宫颈癌的主要进步是认识到HPV DNA已整合
几乎所有晚期宫颈肿瘤中的人类基因组。 HPV DNA的人类基因组整合1)
稳定地将病毒性癌基因与宿主细胞相关联,2)可能驱动宿主癌基因的表达,
HPV DNA插入的位点,3)也会引起人类基因组重排。 HPV集成是
被认为是在人类基因组中随机发生的,但是肿瘤中综合的HPV DNA通常插入
独立肿瘤中的数十个共同基因,这表明克隆增殖和生存优势
在这些位置插入的细胞。在我的研究实验室培训的最初阶段,我
开发了一个广泛的新生研究计划,以1)检测和映射单个单一的HPV-Human DNA连接
核苷酸分辨率(杂交捕获 +下一代测序,HC + NGS),2)彻底
表征整合病毒DNA结构,3)描述两个宫颈的转录组景观
发育不良和癌临床样本。我还将HC+NGS分析应用于最近开发的细胞
培养模型,HPV圆形DNA偶发在人类原发性角质形成细胞中复制。我
发现HPV DNA积分在该模型中有效地发生,因此提供了一个有效的系统来研究HPV
DNA整合及其功能后果。据我所知,这是执行此操作的第一个系统
研究类型。我检测到集成到人类基因组中多个位点的HPV,其中一些被检测到
多次表明包含它们的细胞的克隆扩展。我假设HPV DNA整合是一个
促进细胞克隆扩张的关键分子事件,并促进发育不良的发展和
侵入性宫颈癌。在此应用中,我试图通过生成和使用来发展我的实验室技能
研究HPV整合对患者克隆扩张的时空后果的新工具
使用多色,相间DNA鱼类测定法(AIM 1)的衍生,进行性宫颈发育不良病变;评估
培养角质形成细胞的致瘤特性(AIM 2),最后测试转录激活的作用
在扩展的克隆种群中的人类基因的侧翼(AIM 3)。我将利用一个新颖的条形码系统
基于感兴趣克隆中GFP的CRISPR激活以及定制重组HPV准病毒
谱系迹线扩展的HPV DNA积分克隆的方法。我将对
5年期限为综合K08职业发展奖的一部分。和我的副手博士
克里斯蒂娜·蒙塔格纳(Cristina Montagna)和杰克·伦茨(Jack Lenz)博士,我们制定了一项培训计划,重点是实验室科学和
实现我的职业目标的方法是成为一名完全独立且资助的临床医生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anne Van Arsdale其他文献
Anne Van Arsdale的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anne Van Arsdale', 18)}}的其他基金
Pathogenic role of human papillomavirus (HPV) DNA Integration and clonal expansion in cervical tumorigenesis
人乳头瘤病毒 (HPV) DNA 整合和克隆扩增在宫颈肿瘤发生中的致病作用
- 批准号:
10700102 - 财政年份:2022
- 资助金额:
$ 26.39万 - 项目类别:
相似国自然基金
基于条形码谱系追踪和CRISPR高通量筛选发现CXCL12增强结直肠癌细胞免疫治疗的分子机制研究
- 批准号:82303735
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于DNA荧光条形码的RNA m6A位点空间分辨多重成像分析研究
- 批准号:32301256
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于代谢组差异分析与DNA宏条形码技术“中药材-提取物-制剂”普适的人参属中药鉴别研究
- 批准号:82374030
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
DNA计时器条形码的构建及其在多重检测与多重原位成像中的应用
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
基于DNA纳米条形码探针的核酸多重检测
- 批准号:32201175
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Decoding synovial CD4+ T cell antigen specificities in Rheumatoid Arthritis
解码类风湿性关节炎滑膜 CD4 T 细胞抗原特异性
- 批准号:
10569878 - 财政年份:2023
- 资助金额:
$ 26.39万 - 项目类别:
ShEEP Request for NanoString GeoMx Digital Spatial Profiling System
ShEEP 请求 NanoString GeoMx 数字空间剖析系统
- 批准号:
10741001 - 财政年份:2023
- 资助金额:
$ 26.39万 - 项目类别: